Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Semigran Insider Profile
4 Followers
Marc Semigran, CMO at MyoKardia, holds 6.72K shares in Edgewise Therapeutics (Ticker: EWTX), holds 0.00 shares in Renovacor (Ticker: RCOR), holds 1.11K shares in MyoKardia (Ticker: MYOK).
Marc Semigran MyoKardia (MYOK)CMO
MyoKardia (MYOK)
CMO
Not Ranked
Marc Semigran has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CDO
Roles that Marc Semigran holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marc Semigran
Marc Semigran's Trading History
MyoKardia
Jan 09, 2019
―
Uninformative Sell
22.88K
$249.65K
Renovacor
Dec 05, 2022
―
Uninformative Buy
―
$0.00
Edgewise Therapeutics
Dec 27, 2024
CDO
Uninformative Buy
265.60K
$176.36K
List of latest transactions for each holding click on a transaction to see Marc Semigran's performance on stock
You May Also Like
Marc Semigran insider profile FAQ
What is the percentage of profitable transactions made by Marc Semigran?
The percentage of profitable transactions made by Marc Semigran is ―.
What is the average return per transaction made by Marc Semigran?
The average return per transaction made by Marc Semigran is ―.
What stocks does Marc Semigran hold?
Marc Semigran holds: MYOK, RCOR, EWTX stocks.
What was Marc Semigran’s latest transaction?
Marc Semigran latest transaction was an Uninformative Buy of $265.60K.
What was Marc Semigran's most profitable transaction?
Marc Semigran’s most profitable transaction was an Informative Sell of EWTX stock on December 27, 2024. The return on the trade was 15.90%.
What is Marc Semigran's role in MyoKardia?
Marc Semigran's role in MyoKardia is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.